Havener's Ocular Pharmacology

7th Edition

edited by: T.F. Mauger & L.C. Laxson & M. Slabaugh

Price: € 90.00 / US $ 100.00

Publication details: Book. 2022. xviii and 366 pages. Publication date: 2022-04-22. Hardbound. A4

ISBN: 978-90-6299-278-2 (ISBN 10: 90-6299-278-1; Kugler Publications)

It is humbling to know the book we three, and our many contributors, labored to complete was accomplished by a single author not once, but five times. Two of us trained as residents under Dr. Havener and can attest that he was a remarkable human being. He was able to both quote philosophy and the latest paper at Grand Rounds while growing the largest pumpkins in the county, which he loved to give to the children of his trainees and faculty at annual picnics on his farm. He was extraordinarily devoted to his patients and was for many years one of the few ophthalmologists in the Midwest performing scleral buckling surgery for retinal detachments.

The rapidity of change in medicine and medical therapy has only accelerated since 1983. Many new classes of drugs are available since the last edition, including the prostaglandin analogs, vascular endothelial growth factor inhibitors, and Rho-kinase inhibitors. At the same time, many older drugs are now rarely or never used.

The goal of this text is to help frame the old and the new in ocular pharmacology for physicians, optometrists, and students of pharmacology and visual science. Our hope is that this book will serve as a guide to current medications and also provide a framework to aid the reader in properly positioning new therapeutic options as they become available.

We want to acknowledge the tremendous work of all of the contributors. Andrea Inman at The Ohio State University coordinated the authors and students. Will Bloom, Valerie Mauger, and Nathaniel Dusseau labored for many hours as student assistants in the referencing and editing of many of the chapters of this edition; their assistance was invaluable. We also wish to acknowledge the advice and work of our publisher, Simon Bakker.

Most importantly, we want to thank our editor Silvia Sanchez Di Martino, whose tireless efforts through challenging times are responsible for this text being completed. Her attention to detail in the diverse areas and many references was remarkable. Any remaining deficiencies are totally accountable to the authors.

Finally, the culture of an academic institution is critical to allow a work such as this to be completed. We are blessed to have outstanding and supportive Deans at our Medical Schools at The Ohio State University, West Virginia University, and at the various other academic medical centers represented by our many contributors.

Thomas F. Mauger, MD L.
Carol Laxson, MD, PhD
Mark Slabaugh, MD

Table of Contents

Kugler
Publications

Since 1974 a creative and efficient global niche player in the field of medical publishing

Havener's Ocular Pharmacology

7th Edition

Preface

Table of Contents